head and neck cancer, squamous cell carcinoma, Radiotherapy, Cisplatin, EGFR inhibition, randomised, phase III, DAHANCA
Breast cancer, Radiotherapy, Tumor-infiltrating lymphocytes, Estrogen receptor, recurrence, survival
Radiogenomics, GWAS, radiation-induced morbidity, breast cancer, SNP, Radiotherapy, adverse event, induration, fibrosis, genome-wide association study, single nucleotide polymorphism
Breast cancer, locoregional radiation therapy, fractionation, simultaneous integrated boost
